Condition
Central Nervous System Infection
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown3
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07435649Not ApplicableNot Yet RecruitingPrimary
Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection
NCT03960905UnknownPrimary
A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System
NCT01438879UnknownPrimary
Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)
NCT00172393UnknownPrimary
Long Term Outcomes of EV71 CNS Infection
Showing all 4 trials